Recent Developments in Drug Discovery for Leishmaniasis and Human African Trypanosomiasis
نویسندگان
چکیده
Human African Trypanosomiasis Advait S. Nagle,† Shilpi Khare,† Arun Babu Kumar,‡ Frantisek Supek,† Andriy Buchynskyy,‡ Casey J. N. Mathison,† Naveen Kumar Chennamaneni,‡ Nagendar Pendem,‡ Frederick S. Buckner, Michael H. Gelb,‡,§ and Valentina Molteni*,† †Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States ‡Departments of Chemistry, Biochemistry, and Medicine, University of Washington, Seattle, Washington 98195, United States
منابع مشابه
Recent developments in rationally designed multitarget antiprotozoan agents.
Protozoan infections are the leading cause of morbidity and mortality among parasitic infections of humans, accounting for approximately 800 thousand mortalities and a loss of more than 30 million disability-adjusted life years annually. The major protozoan infections of humans, namely malaria, Chagas disease, human African trypanosomiasis, and leishmaniasis, are primarily centered in the tropi...
متن کاملCurrent Developments in the Therapy of Protozoan Infections
Protozoan parasites cause serious human and zoonotic infections, including life-threatening diseases such as malaria, African and American trypanosomiasis, and leishmaniasis. These diseases are no more common in the developed world, but together they still threaten about 40% of the world population (WHO estimates). Mortality and morbidity are high in developing countries, and the lack of vaccin...
متن کاملAntiparasitic therapy.
Parasitic diseases affect more than 2 billion people globally and cause substantial morbidity and mortality, particularly among the world's poorest people. This overview focuses on the treatment of the major protozoan and helminth infections in humans. Recent developments in antiparasitic therapy include the expansion of artemisinin-based therapies for malaria, new drugs for soil-transmitted he...
متن کاملNew developments in human African trypanosomiasis.
PURPOSE OF REVIEW To review recent literature on human African trypanosomiasis, focussing on genome sequencing, diagnosis and drug discovery, and typing of trypanosomes. RECENT FINDINGS The most important recent development has been the completion of the Trypanosoma brucei genome which will greatly facilitate the discovery of new drug targets and genetic markers. Correct staging of the diseas...
متن کاملDrug discovery and development for neglected diseases: the DNDi model
New models of drug discovery have been developed to overcome the lack of modern and effective drugs for neglected diseases such as human African trypanosomiasis (HAT; sleeping sickness), leishmaniasis, and Chagas disease, which have no financial viability for the pharmaceutical industry. With the purpose of combining the skills and research capacity in academia, pharmaceutical industry, and con...
متن کامل